Skip to content
Low DoseGLP-1Providers

Evidence review

Questions to Ask a GLP-1 Microdose Provider

Check the pharmacy, exact product, refill instructions, full payment terms and clinical support before buying a GLP-1 microdose program.

Written Lena Ortiz

On this page

Before paying for a GLP-1 microdose program, ask what medicine you would receive, who prescribes and dispenses it, what you owe over the full commitment, and who handles problems after delivery. A low monthly headline does not answer those questions. This checklist helps you obtain comparable answers without treating a seller's marketing language as clinical evidence.

Featured partner

CoreAge Rx

$149–$199/mo microdose ($99–$149 standard)

Two named microdosing programs with their own monthly prices, sold beside standard plans that cost less.

Check availability
Category
Telehealth · GLP-1 microdose
Pricing
Flat monthly price
Support
Clinician review included
Labs
No labs required

Advertising disclosure · an affiliate partner. We may earn a commission at no extra cost to you.

Partner

System Labs

One flat month-to-month figure covering every dose of a tirzepatide-only program, behind a first-month introductory price.

$179/mo flat · $99 first month

Check System Labs availability

FDA recommends obtaining a prescription and using a state-licensed pharmacy. It also warns against claims that a compounded medicine is the same as an FDA-approved product 1. Those are useful starting points, but the service and billing details still need to be checked for each program.

What matters for a low-dose plan

  • Get the exact product, prescriber and dispensing pharmacy identified.
  • Compare upfront payment, renewals and commitment terms.
  • Confirm who answers clinical and measuring questions after delivery.
Sources and limitations are explained below.

Ask what "microdose" means in this program

The word can describe a separately sold product, a clinician-adjusted prescription or simply marketing around a standard plan. Ask the provider to explain which meaning applies before deciding whether the price is relevant to you.

A clear answer should identify the active ingredient, route and whether the product is FDA-approved or compounded. It should also explain that prescribing follows an evaluation rather than guaranteeing a particular dose at checkout. Do not ask a sales representative to choose a dose; ask who makes the clinical decision and when you can discuss it.

Our microdosing evidence guide separates what has been studied from what is inferred. A provider's confidence is not an additional clinical trial, and a program name does not establish an approved indication.

Identify the prescriber and the pharmacy separately

The company running the website may not be the medical practice or the dispensing pharmacy. Ask for the identities and contact details of the organizations responsible for your care and medicine.

A response such as "a 503A pharmacy" describes a category, not the name of the pharmacy that will dispense your prescription. Ask which pharmacy is expected to fill it and how you will be told if that changes. Check licensure through the relevant official state resource rather than relying only on a logo in a footer.

FDA has identified fraudulent GLP-1 labels, including labels that named pharmacies that did not make the medicine. If the package or pharmacy identity is unexpected, verify it before use 1.

Compare the whole commitment

Request the amount due at checkout, the billing interval, the renewal price and the minimum commitment. Ask whether medicine, clinician visits, laboratory work, shipping and supplies are included or separate. Keep a copy of the answer and the terms available before you pay.

As an illustration, a plan advertised as $100 a month but billed $600 upfront is a six-month payment commitment. It is not the same transaction as paying $100 and deciding next month whether to continue. That example is arithmetic, not a quoted provider offer.

Ask whether the charge changes with medication or prescribed dose. A lower dose may leave the subscription price unchanged. Our dose-based pricing guide explains how to compare that question without assuming less medicine always means a smaller bill.

Read cancellation and refund terms before the intake

Find out when a charge becomes nonrefundable and what happens if you are not prescribed treatment. Ask whether cancellation stops only the next renewal or also affects an unshipped order. If a multi-month payment is required, ask whether unused months can be refunded and under what written terms.

Do not treat "cancel anytime" as a complete refund policy. It may describe future billing while leaving the current payment unchanged. If a sales message and the published terms differ, ask the provider to explain the difference in writing.

There is no need to assume the worst to ask these questions. The purpose is to know what you are committing to and to compare programs on the same basis.

Check the refill and measuring support

Ask how the program communicates a concentration change and who explains the syringe supplied with a compounded vial. FDA has documented dosing errors associated with confusing units, concentrations and measuring instructions 2.

A useful service answer names a responsible clinician or pharmacist and gives a way to contact them. A generic instructional video may be helpful, but it does not resolve instructions that do not match your own label.

Our concentration-change guide explains what to check on a new vial. Also ask what to do if shipping is delayed, packaging is damaged or the medicine's storage conditions are uncertain. Keep the packaging until the dispensing pharmacy has answered those questions.

Know how follow-up works

Ask how often treatment is reviewed, how to report side effects, when a clinician responds and what happens outside normal hours. A billing support inbox and a clinical service are different things. Confirm which channel you should use for each.

If you have another clinician managing diabetes, kidney disease, eye disease or reproductive care, ask how the provider coordinates with them. A program that relies on your health history needs an accurate, complete history rather than only the facts that fit an advertisement.

An emergency should not be routed through a routine refill form. The provider should be able to explain the limits of its service and how it directs urgent concerns.

Use reviews as a starting point

A review can compare what a company publishes, but it cannot guarantee your eligibility, future service or exact prescription. Prices and terms can change. Check the current written offer before purchasing and keep the evidence that applies to your transaction.

Our provider reviews focus on published program terms and the cost implications of using less medication. Commercial relationships are explained in our funding disclosure. The comparison can help narrow questions; the final answers still need to come from the organization taking responsibility for the prescription and payment.

The strongest comparison is not the longest list of reassuring adjectives. It is a small set of clear answers: the product, the pharmacy, the full cost, the cancellation terms and the clinical contact.

Frequently asked

Does a named pharmacy prove a compounded medicine is FDA-approved?

No. Compounded medicines are not FDA-approved. The pharmacy identity is important for verification and accountability, but it does not change the product approval status.

Does taking less medicine always lower the subscription price?

No. Some programs charge a flat plan price. Ask whether your payment changes with the prescribed dose and compare the full commitment.

What should I save before paying?

Keep the written offer, full billing and cancellation terms, expected product details and the contact information for clinical and pharmacy questions.

References

  1. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  2. U.S. Food and Drug Administration (2024). Dosing errors associated with compounded injectable semaglutide products. FDA. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Continue reading